Furthermore, in comparison with HFD-fed C57 WT mice, HFD-fed APP/PS1 demonstrated aggregated hyperglycemia, hypercholesterolemia, hyperinsulinemia, and enhanced hepatic lipid deposition, accompanied by decreased GLUTs expression in liver and skeletal muscle (Figure 2). This evidence concerns the gene APP and hyperinsulinism.